Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HMG-CoA Reductase Inhibitor Toxicity”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Looking for participantsNCT05559164
What this trial is testing

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Who this might be right for
Cardiac ToxicityEarly-stage Breast Cancer
Rutgers, The State University of New Jersey 60
Testing effectiveness (Phase 2)Study completedNCT01988571
What this trial is testing

Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

Who this might be right for
Breast CancerLymphoma
Wake Forest University Health Sciences 279
Post-approval studies (Phase 4)Looking for participantsNCT04499859
What this trial is testing

Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI

Who this might be right for
Myocardial InfarctionStatin Adverse ReactionHMG-CoA Reductase Inhibitor Toxicity
Kiyuk Chang, MD,PhD 3,548
Post-approval studies (Phase 4)WithdrawnNCT00127335
What this trial is testing

Is Myopathy Part of Statin Therapy (IMPOSTER-16)

Who this might be right for
Myopathic Conditions
Scripps Health
Not applicableStudy completedNCT00797407
What this trial is testing

Effectiveness of Creatine in Preventing Muscle Aching From Cholesterol-Lowering Statin Drugs

Who this might be right for
HypercholesterolemiaAchesCramps+1 more
The Cleveland Clinic 12
Not applicableActive Not RecruitingNCT04636138
What this trial is testing

Pharmacogenomic Modulators of Impaired Exercise Adaptation in Statin Users

Who this might be right for
HMG-CoA Reductase Inhibitor Toxicity
University of Kansas Medical Center 5
Post-approval studies (Phase 4)Not Yet RecruitingNCT07254221
What this trial is testing

Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients

Who this might be right for
Anthracycline-induced Cardiac ToxicityBreast CancerAnthracycline Related Cardiotoxicity in Breast Cancer+1 more
Shiraz University of Medical Sciences 400
Testing effectiveness (Phase 2)Ended earlyNCT02096588
What this trial is testing

Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin

Who this might be right for
Breast CancerStage I Breast CancerStage II Breast Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 34
Post-approval studies (Phase 4)Study completedNCT01013103
What this trial is testing

Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients

Who this might be right for
Coronary Artery DiseaseHMG-CoA Reductase Inhibitor ToxicityAtherosclerosis+2 more
Hippocration General Hospital 72